Education Library

Robert Yeh, MD, discusses how we analyze data, make treatment decisions and participate in developing clinical evidence.

Aditya Bharadwaj, MD, an investigator for the RESTORE EF study, presents a case study epitomizing the results from the trial.

Mitul Patel, MD, discusses the RESTORE EF study and a successful case of improved ejection fraction with complete revascularization.

Jason Wollmuth, MD, describes best practice techniques for Impella-supported complete revascularization in a RESTORE EF case.

Aditya Bharadwaj, MD, walks through the first PROTECT IV case enrolled at Loma Linda University Health Care in California.

Babar Basir, MD, discusses how hemodynamics can help clinicians decide whether to use mechanical circulatory support (MCS) in patients undergoing high-risk PCI.

Mihas Kodenchery, MD, and Laura Rodriguez, NP, discuss the low mortality and low complication rates in their high-volume high-risk PCI practice.
 

William O’Neill, MD, discusses the current state of mechanical circulatory support for AMI cardiogenic shock.
 

Amir Kaki, MD, describes best practices and practical considerations for optimizing care of patients with AMI cardiogenic shock prior to leaving the cath lab.

Bobby Yeh, MD, discusses how real-world evidence factors into treatment decisions made every day in clinical practice.

Arman Kilic, MD, discusses his experiences with collaboration between interventional cardiology and cardiac surgery, particularly regarding Impella 5.5® with SmartAssist® and ECpella.

Navin Kapur, MD, discusses the latest science underlying reperfusion and unloading and how it led to the STEMI-DTU pilot and pivotal trials.

Kate Kearney, MD, discusses studies and strategies for revascularization in heart failure with reduced ejection fraction.

Adam DeVore, MD, reviews data on evaluating patients with heart failure for CAD and discusses opportunities to improve assessment rates for CAD in these patients.

Gregg Stone, MD, presents the newly underway PROTECT IV randomized controlled transcatheter heart failure therapy trial at THT 2022.